On July 9, after bargaining for more than a year, Menarini Group – the largest pharmaceutical group in Italy – signed an agreement with its RSUs and the Femca-Cisl, Filctem-CGIL and Uiltec-UIL unions to apply ‘defensive solidarity contracts’ (shared working time) in four undertakings – Menarini, Lusofarmaco, Laboratori Guidotti and Malesci. This is instead of the 730 job cuts the group had announced. (Ref. 130482)
Because of ‘excess staff’ in the Italian pharmaceutical industry following the law enforced in August 2012 that provides that physicians have to write down the active ingredient in their prescription for drugs whose patent is now public, the group’s organization is now “inappropriate for the new requirements of the reference market.” Therefore, the agreement reads, it is in need of an “in-depth review.” For instance, at Menarini IFR, where 660 employees (out of 980) are “outside operational f
…Do you have information to share with us?